🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07643415
Recruiting Not applicable

Spinal Versus General Anesthesia in Open Simple Prostatectomy

NCT07643415 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-04-29
Last updated
2026-06-16

Condition(s) studied

Urologic NeoplasmsBenign Prostatic HyperplasiaAnesthesia

Investigational drug(s) / intervention(s)

Spinal anesthesiaGeneral anesthesia

Spinal anesthesia: Spinal anesthesia will be performed at the L3-4 or L4-5 interspace under aseptic conditions using hyperbaric bupivacaine. Light sedation may be administered when clinically required.

General anesthesia: General anesthesia will be induced and maintained according to the institutional standard protocol. Airway management, mechanical ventilation, anesthetic maintenance, antiemetic prophylaxis, and multimodal analgesia will be applied according to routine clinical practice.

Study summary

Open simple prostatectomy is still performed for selected patients with benign prostatic hyperplasia, particularly in cases with large prostate volume. Postoperative bleeding, hematuria, clot retention, and transfusion requirement are clinically important complications after this procedure.

This prospective randomized controlled trial will compare the effects of spinal anesthesia and general anesthesia on postoperative bleeding in patients undergoing open simple prostatectomy. Participants will be randomized into two groups: spinal anesthesia or general anesthesia. Tranexamic acid or any additional hemostatic agent will not be used. Postoperative bleeding will be assessed using hemoglobin and hematocrit changes, transfusion requirement, hematuria, clot retention, need for bladder irrigation, and bleeding-related reintervention.

The study aims to determine whether spinal anesthesia is associated with reduced postoperative bleeding compared with general anesthesia in open simple prostatectomy.

Eligibility

Sex
MALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Male patients aged 18 years or older. * Diagnosis of benign prostatic hyperplasia (BPH). * Scheduled to undergo open simple prostatectomy. * American Society of Anesthesiologists (ASA) physical status I-III. * Ability to provide written informed consent. Exclusion Criteria: * Refusal or inability to provide informed consent. * Patients scheduled for radical prostatectomy due to prostate cancer. * Emergency surgery. * Known coagulation disorders or clinically significant thrombocytopenia. * Ongoing anticoagulant or antiplatelet therapy that cannot be discontinued according to institutional protocols. * Contraindication to spinal anesthesia. * Participation in another interventional clinical trial that may affect study outcomes. * Administration of tranexamic acid or any additional hemostatic agent during the perioperative period.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Hitit university Çorum Turkey (Türkiye) Recruiting
hitit Üniversity Çorum Turkey (Türkiye) Recruiting

More Hitit University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07643415 on ClinicalTrials.gov ↗ ← All trials in Turkey